九强新闻
Roche and BSBE signed Reagent Purchase Agreement to Supplement the Coagulation Test Menu
Published：2021-10-08
Source：[英文]九强生物
Roche Diagnostics and Beijing Strong(BSBE) signed coagulation reagent purchase agreement on September 21, to supplement Roche diagnostics' coagulation test menu. The product shall be distributed from October 1, 2021 to September 30, 2027.
The cooperation between BSBE and Roche Diagnostics has further expanded their respective market shares in the field of coagulation analysis and diagnosis, and has a positive and significant significance for the development of both enterprises. This cooperation also shows that BSBE’s blood coagulation diagnostic products have been recognized by well-known international companies in terms of R&D, production and quality control.
And BSBE will also seize this opportunity, through mutual communication and learning, constantly improve our own level, to provide customers with better products and services.
The cooperation between BSBE and Roche Diagnostics has further expanded their respective market shares in the field of coagulation analysis and diagnosis, and has a positive and significant significance for the development of both enterprises. This cooperation also shows that BSBE’s blood coagulation diagnostic products have been recognized by well-known international companies in terms of R&D, production and quality control.
And BSBE will also seize this opportunity, through mutual communication and learning, constantly improve our own level, to provide customers with better products and services.